Cite

HARVARD Citation

    Biswal, S. et al. (2020). Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial. Lancet. 395 (10234), pp. 1423-1433. [Online]. 
  
Back to record